Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 8, 2014, Pages 669-678

  Stavniichuk, Roman ^a,d   Shevalye, Hanna ^a,e   Lupachyk, Sergey ^a,e   Obrosov, Alexander ^a,e   Groves, John T ^b   Obrosova, Irina G ^d   Yorek, Mark A ^c,e  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Diabetic neuropathy; Nitrosative stress; Oxidative stress; Peroxynitrite; Superoxide

Indexed keywords

ANTIDIABETIC AGENT; EPICATECHIN GALLATE; FE(III) TETRAMESITYLPORPHYRIN OCTASULFONATE; GLUCOSE; HEMOGLOBIN A1C; PEROXYNITRITE; UNCLASSIFIED DRUG; 5,10,15,20-TETRAKIS(2,4,6-TRIMETHYL-3,3-DISULFONATOPHENYL)PORPHYRINATO IRON(III); ANTIOXIDANT; CATECHIN; FERRIC ION; METALLOPORPHYRIN; NERVE PROTEIN; PEROXYNITROUS ACID;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYST; CONTROLLED STUDY; DECOMPOSITION; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOALGESIA; MALE; MOTOR NERVE CONDUCTION; MOUSE; NERVE FIBER; NITRATION; NONHUMAN; PATHOGENESIS; PROTEIN MODIFICATION; PROTEIN NITRATION; SENSORY NERVE CONDUCTION; SENSORY SYSTEM PARAMETERS; TACTILE STIMULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DRUG EFFECTS; EPIDERMIS; INNERVATION; METABOLISM; MOTONEURON; NERVE CONDUCTION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; REACTION TIME; SENSORY NERVE CELL; SPINAL GANGLION;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CATECHIN; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; EPIDERMIS; FERRIC COMPOUNDS; GANGLIA, SPINAL; MALE; METALLOPORPHYRINS; MICE, INBRED C57BL; MOTOR NEURONS; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM; PEROXYNITROUS ACID; REACTION TIME; SENSORY RECEPTOR CELLS;

EID: 84905082724     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2549     Document Type: Article

References (58)

1. DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Int Med 1995; 122: 561-568.
2. Low PA, Nickander KK. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 1991; 40: 873-877.
3. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin diabetic rats. Diabetologia 1994; 37: 449-459.
4. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 1995; 38: 129-134.
5. Obrosova IG, Van Huysen C, Fathallah L, Cao X, Stevens MJ, Greene DA. Evaluation of α1- adrenoceptor antagonist on nerve function, metabolism and antioxidative defense. FASEB J 2000; 14: 1548-1558.
6. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of dl-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 2000; 49: 1006-1015.
7. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2000; 50: 1927-1937.
8. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 2003; 37: 33-40.
9. Yorek MA. The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 2003; 37: 471-480.
10. Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 1988; 4: 323-337.
11. Kador PF. The role of aldose reductase in the development of diabetic complications. Med Res Rev 1988; 8: 325-352.
12. Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA. Complications: neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-1925.
13. Sima AA, Dunlap JA, Davidson EP, et al. Supplemental myoinositol prevents l-fucose-induced diabetic neuropathy. Diabetes 1997; 46: 301-306.
14. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994; 94: 853-859.
15. Fernyhough P, Brewster WJ, Fernandes K, Diemel LT, Tomlinson DR. Stimulation of nerve growth factor and substance P expression in the iris-trigeminal axis of diabetic rats - involvement of oxidative stress and effects of aldose reductase inhibition. Brain Res 1998; 802: 247-253.
16. Sayers NM, Beswick LJ, Middlemas A, et al. Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats. Diabetes 2003; 52: 2372-2380.
17. Huang TJ, Price SA, Chilton L, et al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003; 52: 2129-2136.
18. Purves T, Middlemas A, Agthong S, et al. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001; 15: 2508-2514.
19. Price SA, Agthong S, Middlemas AB, Tomlinson DR. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes 2004; 53: 1851-1856.
20. Greene DA, Stevens MJ, Obrosova I, Feldman EL. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 1999; 375: 217-223.
21. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1998; 46(Supl. 2): 38S-42S.
22. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52: 165-171.
23. Ametov AS, Barinov A, Dyck PJ, et al. SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26: 770-776.
24. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2003; 21: 114-121.
25. Obrosova IG. How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol 2002; 50: 3-35.
26. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
27. Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and perxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005; 12: 267-275.
28. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007; 6: 662-680.
29. Kowluru RA, Kanwar M, Kennedy A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007: 21976.
30. Ihnat MA, Thorpe JE, Ceriello A. Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabet Med 2007; 24: 582-586.
31. Obrosova IG, Mabley JG, Zsengeller Z, et al. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J 2005; 19: 401-403.
32. Cheng C, Zochodne DW. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 2003; 52: 2363-2371.
33. Drel VR, Mashtalir N, Ilnytska O, et al. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 2006; 55: 3335-3343.
34. Drel VR, Pacher P, Vareniuk I, et al. A Peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur J Pharmacol 2007; 569: 48-58.
35. Vareniuk I, Pavlov IA, Drel VR, et al. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol 2007; 205: 425-436.
36. Bell SR. PhD thesis. Princeton University, 2007; p243.
37. Shimanovich R, Groves JT. Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch Biochem Biophys 2007; 387: 307-317.
38. Stavniichuk R, Drel VR, Shevalye H, et al. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp Neurol 2011; 230: 106-113.
39. +-exchanger-1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats. Am J Physiol 2013; 305: E396-E404.
40. Ceriello A. Nitrotyrosine: new findings as a marker of postprandial oxidative stress. Int J Clin Pract 2003; 129: 51-58.
41. Ceriello A, Piconi L, Esposito K, Giugliano D. Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes. Diabetes Care 2007; 30: 1694-1698.
42. Drel VR, Pacher P, Stevens MJ, Obrosova IG. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Rad Biol Med 2006; 40: 1454-1465.
43. Du Y, Smith MA, Miller CM, Kern TS. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurchem 2002; 80: 771-779.
44. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87: 1123-1132.
45. Hoeldtke RD. Nitrosative stress in early Type 1 diabetes. Clin Auton Res 2003; 13: 406-421.
46. Obrosova IG, Pacher P, Szabo C, et al. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetic complications. Diabetes 2005; 54: 234-242.
47. Szabo C, Mabley JG, Moeller SM, et al. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med 2002; 8: 571-580.
48. Szabo C, Zanchi A, Komjati K, et al. Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002; 106: 2680-2686.
49. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 2000; 57: 1968-1972.
50. Drel VR, Pacher P, Vareniuk I, et al. Evaluation of the peroxynitrite decomposition catalyst Fe(III)tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int J Mol Med 2007; 20: 783-792.
51. Christianson JA, Riekhof JT, Wright DE. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 2003; 179: 188-199.
52. Calcutt NA, Freshwater JD, Hauptmann N, Taylor EM, Mizisin AP. Protection of sensory function in diabetic rats by neotrofin. Eur J Pharmacol 2006; 534: 187-193.
53. Calcutt NA. Modeling diabetic sensory neuropathy in rats. Methods Mol Med 2004; 99: 55-65.
54. Ilnytska O, Lyzogubov VV, Stevens MJ, et al. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 2006; 55: 1686-1694.
55. Calcutt NA. Potential mechansims of neuropathic pain in diabetes. Int Rev Neurobiol 2002; 50: 205-228.
56. Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004; 47: 718-724.
57. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005; 5: 421-440.
58. Obrosova IG, Drel VR, Oltman CL, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol 2007; 293: E1645-E1655.